Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell death

Journal of Neurochemistry

Volumn 125, Issue 3, 2013, Pages 473-485

  De Simoni, Stéphanie ^a   Linard, Dominique ^a   Hermans, Emmanuel ^a   Knoops, Bernard ^a   Goemaere, Julie ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

calcium; ER; mitochondria; MPP +; neurodegeneration; peroxiredoxin

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2 AMINOETHOXYDIPHENYLBORANE; CALCIUM ION; CALPAIN; CASPASE 9; DANTROLENE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; NIMODIPINE; PEROXIREDOXIN 5; PROTEIN BAX;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL INTERACTION; DNA DAMAGE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; BORON COMPOUNDS; CALCIUM; CALPAIN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; DOPAMINE AGENTS; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; HYDRO-LYASES; MICE; MITOCHONDRIA; NEUROBLASTOMA; PEROXIREDOXINS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS; TRANSFECTION; TYROSINE;

MAMMALIA;

EID: 84876675198     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12117     Document Type: Article

References (66)

1. Arduino D. M., Esteves A. R., Cardoso S. M., and, Oliveira C. R., (2009) Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease. Neurochem. Int. 55, 341-348.
2. Banmeyer I., Marchand C., Verhaeghe C., Vucic B., Rees J. F., and, Knoops B., (2004) Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic. Biol. Med. 36, 65-77.
3. Banmeyer I., Marchand C., Clippe A., and, Knoops B., (2005) Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett. 579, 2327-2333.
4. Bezard E., and, Przedborski S., (2011) A tale on animal models of Parkinson's disease. Mov. Disord. 26, 993-1002.
5. Blandini F., Bazzini E., Marino F., et al,. (2009) Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias. Clin. Neuropharmacol. 32, 133-139.
6. Cadenas E., (2004) Mitochondrial free radical production and cell signaling. Mol. Aspects Med. 25, 17-26.
7. Chan P., DeLanney L. E., Irwin I., Langston J. W., and, Di M. D., (1991) Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J. Neurochem. 57, 348-351.
8. Chen T. S., Koutsilieri E., and, Rausch W. D., (1995) MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57/Bl6 mice. J. Neural Transm. Gen. Sect. 100, 153-163.
9. Chinta S. J., and, Andersen J. K., (2011) Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease. Free Radic. Res. 45, 53-58.
10. Cleeter M. W., Cooper J. M., and, Schapira A. H., (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
11. Collier T. J., Steece-Collier K., McGuire S., and, Sortwell C. E., (2003) Cellular models to study dopaminergic injury responses. Ann. N. Y. Acad. Sci. 991, 140-151.
12. Cox A. G., Winterbourn C. C., and, Hampton M. B., (2010) Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem. J. 425, 313-325.
13. Crocker S. J., Smith P. D., Jackson-Lewis V., et al,. (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23, 4081-4091.
14. Csordas G., and, Hajnoczky G., (2009) SR/ER-mitochondrial local communication: calcium and ROS. Biochim. Biophys. Acta 1787, 1352-1362.
15. De Simoni S., Goemaere J., and, Knoops B., (2008) Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+. Neurosci. Lett. 433, 219-224.
16. Drechsel D. A., and, Patel M., (2010) Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system. J. Biol. Chem. 285, 27850-27858.
17. Dubuisson M., Vander Stricht D., Clippe A., Etienne F., Nauser T., Kissner R., Koppenol W. H., Rees J. F., and, Knoops B., (2004) Human peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett. 571, 161-165.
18. Fall C. P., and, Bennett J. P. Jr, (1999) Characterization and time course of MPP+ -induced apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 55, 620-628.
19. Fang J., Nakamura T., Cho D. H., Gu Z., and, Lipton S. A., (2007) S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc. Natl Acad. Sci. USA 104, 18742-18747.
20. Ferrini M., Wang C., Swerdloff R. S., Sinha Hikim A. P., Rajfer J., and, Gonzalez-Cadavid N. F., (2001) Aging-related increased expression of inducible nitric oxide synthase and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function. Neuroendocrinology 74, 1-11.
21. Garavito-Aguilar Z. V., Recio-Pinto E., Corrales A. V., Zhang J., Blanck T. J., and, Xu F., (2004) Differential thapsigargin-sensitivities and interaction of Ca2+ stores in human SH-SY5Y neuroblastoma cells. Brain Res. 1011, 177-186.
22. Gleichmann M., and, Mattson M. P., (2011) Neuronal calcium homeostasis and dysregulation. Antioxid. Redox Signal. 14, 1261-1273.
23. Goemaere J., and, Knoops B., (2012) Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders. J. Comp. Neurol. 520, 258-280.
24. Hagenston A. M., Rudnick N. D., Boone C. E., and, Yeckel M. F., (2009) 2-Aminoethoxydiphenyl-borate (2-APB) increases excitability in pyramidal neurons. Cell Calcium 45, 310-317.
25. Harbison R. A., Ryan K. R., Wilkins H. M., Schroeder E. K., Loucks F. A., Bouchard R. J., and, Linseman D. A., (2011) Calpain plays a central role in 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in cerebellar granule neurons. Neurotox. Res. 19, 374-388.
26. Hidalgo C., (2005) Cross talk between Ca2+ and redox signalling cascades in muscle and neurons through the combined activation of ryanodine receptors/Ca2+ release channels. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 360, 2237-2246.
27. Hu H. Z., Gu Q., Wang C., Colton C. K., Tang J., Kinoshita-Kawada M., Lee L. Y., Wood J. D., and, Zhu M. X., (2004) 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J. Biol. Chem. 279, 35741-35748.
28. Joseph S. K., Nakao S. K., and, Sukumvanich S., (2006) Reactivity of free thiol groups in type-I inositol trisphosphate receptors. Biochem. J. 393, 575-582.
29. Karplus P. A., and, Poole L. B., (2012) Peroxiredoxins as molecular triage agents, sacrificing themselves to enhance cell survival during a peroxide attack. Mol. Cell 45, 275-278.
30. Knoops B., Clippe A., Bogard C., Arsalane K., Wattiez R., Hermans C., Duconseille E., Falmagne P., and, Bernard A., (1999) Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J. Biol. Chem. 274, 30451-30458.
31. Knoops B., Goemaere J., Van der Eecken V., and, Declercq J. P., (2011) Peroxiredoxin 5: structure, mechanism, and function of the Mammalian atypical 2-cys peroxiredoxin. Antioxid. Redox Signal. 15, 817-829.
32. Kropotov A., Gogvadze V., Shupliakov O., Tomilin N., Serikov V. B., Tomilin N. V., and, Zhivotovsky B., (2006) Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells. Exp. Cell Res. 312, 2806-2815.
33. Langston J. W., Ballard P., Tetrud J. W., and, Irwin I., (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
34. Lee D. H., Han Y. S., Han E. S., Bang H., and, Lee C. S., (2006) Differential involvement of intracellular Ca2+ in 1-methyl-4-phenylpyridinium- or 6-hydroxydopamine-induced cell viability loss in PC12 cells. Neurochem. Res. 31, 851-860.
35. Lee Y. M., Park S. H., Shin D. I., et al,. (2008) Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J. Biol. Chem. 283, 9986-9998.
36. Li Y., Hu X., Liu Y., Bao Y., and, An L., (2009) Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology 56, 580-589.
37. Mao P., Meshul C. K., Thuillier P., Goldberg N. R., and, Reddy P. H., (2012) CART peptide is a potential endogenous antioxidant and preferentially localized in mitochondria. PLoS ONE 7, e29343.
38. Mattson M. P., (2007) Calcium and neurodegeneration. Aging Cell 6, 337-350.
39. Mouatt-Prigent A., Karlsson J. O., Agid Y., and, Hirsch E. C., (1996) Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 73, 979-987.
40. Muehlschlegel S., and, Sims J. R., (2009) Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit. Care 10, 103-115.
41. Neumann C. A., Cao J., and, Manevich Y., (2009) Peroxiredoxin 1 and its role in cell signaling. Cell Cycle 8, 4072-4078.
42. Ott M., Gogvadze V., Orrenius S., and, Zhivotovsky B., (2007) Mitochondria, oxidative stress and cell death. Apoptosis 12, 913-922.
43. Peppiatt C. M., Collins T. J., Mackenzie L., Conway S. J., Holmes A. B., Bootman M. D., Berridge M. J., Seo J. T., and, Roderick H. L., (2003) 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate- induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34, 97-108.
44. Plaisant F., Clippe A., Vander Stricht D., Knoops B., and, Gressens P., (2003) Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radic. Biol. Med. 34, 862-872.
45. Qu D., Rashidian J., Mount M. P., et al,. (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55, 37-52.
46. Radi R., (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl Acad. Sci. USA 101, 4003-4008.
47. Rhee S. G., and, Woo H. A., (2011) Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger HO, and protein chaperones. Antioxid. Redox Signal. 15, 781-794.
48. Schapira A. H., and, Jenner P., (2011) Etiology and pathogenesis of Parkinson's disease. Mov. Disord. 26, 1049-1055.
49. Seo M. S., Kang S. W., Kim K., Baines I. C., Lee T. H., and, Rhee S. G., (2000) Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem. 275, 20346-20354.
50. Sorensen I. F., Purup S., and, Ehrich M., (2009) Modulation of neurotoxicant-induced increases in intracellular calcium by phytoestrogens differ for amyloid beta peptide (Abeta) and 1-methyl-4-phenyl-pyridine (MPP(+)). J. Appl. Toxicol. 29, 84-89.
51. Surmeier D. J., Guzman J. N., Sanchez-Padilla J., and, Schumacker P. T., (2011) The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease. Neuroscience 198, 221-231.
52. Toyota H., Yanase N., Yoshimoto T., Moriyama M., Sudo T., and, Mizuguchi J., (2003) Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett. 189, 221-230.
53. Trujillo M., Clippe A., Manta B., Ferrer-Sueta G., Smeets A., Declercq J. P., Knoops B., and, Radi R., (2007) Pre-steady state kinetic characterization of human peroxiredoxin 5: taking advantage of Trp84 fluorescence increase upon oxidation. Arch. Biochem. Biophys. 467, 95-106.
54. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F. F., Yantiri F., Yang L., Beal M. F., and, Andersen J. K., (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21, 9519-9528.
55. Wang M. X., Wei A. Q., Yuan J., Clippe A., Bernard A., Knoops B., and, Murrell G. A. C., (2001) Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem. Biophys. Res. Commun. 284, 667-673.
56. Wang G., Zhou L., Zhang Y., Dong M., Li X., Liu J., and, Niu Y., (2011) Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. Neurosci. Lett. 487, 88-93.
57. Wood D. E., and, Newcomb E. W., (2000) Cleavage of Bax enhances its cell death function. Exp. Cell Res. 256, 375-382.
58. Wood D. E., Thomas A., Devi L. A., Berman Y., Beavis R. C., Reed J. C., and, Newcomb E. W., (1998) Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17, 1069-1078.
59. Xia R., Stangler T., and, Abramson J. J., (2000) Skeletal muscle ryanodine receptor is a redox sensor with a well defined redox potential that is sensitive to channel modulators. J. Biol. Chem. 275, 36556-36561.
60. Xie H. R., Hu L. S., and, Li G. Y., (2010a) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin. Med. J. (Engl.) 123, 1086-1092.
61. Xie J., Duan L., Qian X., Huang X., Ding J., and, Hu G., (2010b) K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production. J. Neurosci. Res. 88, 428-437.
62. Xie H., Chang M., Hu X., et al,. (2011) Proteomics analysis of MPP+-induced apoptosis in SH-SY5Y cells. Neurol. Sci. 32, 221-228.
63. Yuan J., Lipinski M., and, Degterev A., (2003) Diversity in the mechanisms of neuronal cell death. Neuron 40, 401-413.
64. Yuan J., Murrell G. A., Trickett A., Landtmeters M., Knoops B., and, Wang M. X., (2004) Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress. Biochim. Biophys. Acta 1693, 37-45.
65. Zhou C., Huang Y., and, Przedborski S., (2008) Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. N. Y. Acad. Sci. 1147, 93-104.
66. Zundorf G., and, Reiser G., (2011) Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid. Redox Signal. 14, 1275-1288.